ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,870.62
-1.32%
US Tech 100
19,987.20
0.63%
다우존스 지수
43,444.99
-0.70%
Bitcoin
91,845.18
2.20%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. TG Therapeutics Inc (TGTX)

  7. TG Therapeutics Inc (TGTX) 뉴스

TG Therapeutics Inc

TG Therapeutics Inc (TGTX)

NASDAQ
29.54
-1.31
(-4.23%)
마감 16 11월 6:00AM
15분 지연
29.54
0.00
( 0.00% )
시간외 단일가: 6:00PM
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

TGTX 뉴스

공식 뉴스 전용

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
13 11월 2024
TGTX (-4.23%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
13 11월 2024
TGTX (-4.23%)

Form 144/A - Report of proposed sale of securities: [Amend]
Edgar (US Regulatory)
13 11월 2024
TGTX (-4.23%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
13 11월 2024
TGTX (-4.23%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
13 11월 2024
TGTX (-4.23%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
08 11월 2024
TGTX (-4.23%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
06 11월 2024
TGTX (-4.23%)

Form 8-K - Current report
Edgar (US Regulatory)
04 11월 2024
TGTX (-4.23%)

TGTX Discussion

게시물 보기
EarningsCentral EarningsCentral 5 일 전
👍️0
Laster Laster 2 월 전
I think we will see a delayed (few days) response to the news.
I am expecting that this will run to $27 by next week and $30 by October.
Definite buyout candidate within the next year. Especially if interest rates are dropping.
JMO.
👍️0
murocman murocman 2 월 전
Could not agree more.

I don’t think they are long for this corporate world as an independent entity.

Murocman
👍️0
Laster Laster 2 월 전
I had to buy some Premarket. This company is a gold mine IMO.
I love stocks near 52 week high. The upward potential here is limitless.
Really excited for the next few months.
I definitely see this company being bought out in the next 52 weeks.
👍️0
Laster Laster 2 월 전
Great news today. Stock at 52-week high.
Just announced $100 million stock buyback.
Compelling story here.
JMO.
👍️0
Monksdream Monksdream 10 월 전
TGTX new 52 week high
👍️0
InspectorBullit InspectorBullit 11 월 전
this should have a very good day tomorrow absent a market meltdown. MS drug par excellence.
👍️0
murocman murocman 1 년 전
I would think we’d be close to the bottom here? Almost at a 52 week low!

GLTA,

Murocman
👍️ 1
kld2 kld2 1 년 전
Cheap at these levels. Should see $20 again before long. Friday should be interesting. If script numbers are good, like last Friday, the share price should get a good boost. Half way through Q3. Dumb drop from $21 to $9.
👍️ 1
Max77 Max77 1 년 전
$TGTX CEO Weiss buys 100k shares at 10.13. Now has 12 million shares
👍️ 1
murocman murocman 1 년 전
Barely above pre-approval prices. Unbelievable.

Murocman
👍️ 1
teifhals teifhals 1 년 전
Anyone catch that Genetech is starting to air commercials since they are losing share?
👍️0
Rayn_Makr Rayn_Makr 2 년 전
Great call this morning. Nice run today and just the beginning with Europe coming on soon.
After Hours Time (ET) After Hours Price After Hours Share Volume
17:27:17 $30.5 5,000
$152,500 in one trade. Short covering???
Fun to think about market cap in 2024 and 2025.
👍️0
Alan Brown Alan Brown 2 년 전
Where did you find such news?
👍️0
Aquahoya Aquahoya 2 년 전
Has anyone checked out $GSTC? Similar biotech company like $TGTX except its much newer and has a patented formulation combinational therapy already FDA approved set and waiting for clinical trial approval in India for Multiple Sclerosis. It is an over-the-counter stock sitting over .01 just waiting for clinical trials approval. The market cap is on $8,000,000. The therapy isn't specific to the type of multiple sclerosis. So, the potential here is huge. The conservative market share that was done by seasoned professionals in the space, that is on their presentation is in the BILLIONs. Read the history here: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170524593












👍️0
teifhals teifhals 2 년 전
Whens the buyout..?
👍️ 1
Penny chatter Penny chatter 2 년 전
Lol
👍️0
hawkshaw812 hawkshaw812 2 년 전
Looks like tuseday is shorting day .
👍️0
tw0122 tw0122 2 년 전
They have cash and a better MS drug have the price of Roches. Shorts don’t like
👍️0
makinezmoney makinezmoney 2 년 전
$TGTX: Not only that but they must be...............

On the wrong side of the trade.

When you get squeezed on them nards, it never feels good.


No mercy....... TAKE THEM OUT !!!!!!!


GO $TGTX
👍️0
tw0122 tw0122 2 년 전
Analysts keep on giving it bad sell ratings.
That must be a good sign. Analysts for the most part just share selling scam artists
👍️0
makinezmoney makinezmoney 2 년 전
$TGTX: Slowllyy creeping up..... now 11.50 in PreMarket

If it can do exactly what $KALA just did by going over $45, I'm a happy camper


GOOOOOOOOOOOooooooooooooooooooooooooooo hardddddddddddddddddddd



GO $TGTX
👍️0
Ringrock Ringrock 2 년 전
Traded@55.70 Jan 8 ‘21… looks like she’s still got quite a bit togo…
👍️0
shamalamadingdong shamalamadingdong 2 년 전
Dosing of first patients in 30 to 45 days from now/going to the market!!
👍️0
TheFinalCD TheFinalCD 2 년 전
$TGTX No offerings on the horizon per CC

$TGTX No offerings on the horizon per CC lfg— Cooway Trades 🐊 ⛪️🚀🇺🇸🙏🏽 (@cooway) December 29, 2022
👍️0
shamalamadingdong shamalamadingdong 2 년 전
Link to 8;30 webcast/conference call.
https://ir.tgtherapeutics.com/events
👍️0
shamalamadingdong shamalamadingdong 2 년 전
Some informative information, pictures of the packaging, disease overview, and more.
https://ml.globenewswire.com/1.0/snippet/1898/eng
👍️0
shamalamadingdong shamalamadingdong 2 년 전
TG Therapeutics Announces FDA Approval Of BRIUMVI; Company To Host Conference Call On Thursday, December 29, 2022 At 8:30 Am ET
👍️0
airman1 airman1 2 년 전
Given a try; on this one in at 8:47 for a morning was jump !!
See if shorts cover before the weekend ??
👍️0
airman1 airman1 2 년 전
Yeah, we may get mm naked! shorts covering tomorrow. Share price may
spike./;)) early GL$$
👍️0
tw0122 tw0122 2 년 전
They have cash and they would let the price go much higher before another offering
👍️0
tw0122 tw0122 2 년 전
$8.73 after hours On a good note company conference 830am and market makers
👍️0
pennyfinder pennyfinder 2 년 전
Probably an offering coming.
👍️0
tw0122 tw0122 2 년 전
Unfortunately lots of illegal naked shorts courtesy of Gary G but see what happens next few days as more shorts cover.
Never a easy game kept a few shares
👍️0
Cheap Stock Investor Cheap Stock Investor 2 년 전
Damn how low is this going? Not headed in right direction at the moment.
👍️0
tw0122 tw0122 2 년 전
MS drug going to make hundreds of millions..

Dec 28 (Reuters) - TG Therapeutics Inc said on Wednesday that the U.S. health regulator had approved its monoclonal antibody for treating patients with relapsing forms of multiple sclerosis, sending its shares up nearly 9% in afternoon trade.

The approval by the U.S. Food and Drug Administration (FDA) widens the number of such drugs available for treating the disorder to three and may help soften the blow to the company's finances from the withdrawal of its lymphatic cancer drug earlier this year.

TG Therapeutics said it was expecting to launch the drug, branded as Brumvi, in the first quarter of 2023, but did not give details on its pricing.

Jefferies analyst Chris Howerton said ahead of the approval that he was expecting the drug to be priced in the range of $30,000 per patient per year. In comparison, Roche's Ocrevus has a current list price of about $68,000 annually.

Multiple sclerosis is a neurological disease in which the immune system attacks the brain cells causing motor disabilities. It affects about 400,000 people in the United States, according to the National Institutes of Health.

Unlike other MS drugs that target T cells, Brumvi belongs to a class of drugs that tackles B cells' role in driving the inflammation that is central to neurological disease.

The approval, which comes with a warning of infusion reactions from the drug, was based on a late-stage study that showed the drug was effective in reducing the annualized relapse rates in patients. (Reporting by Sriparna Roy, Khushi Mandowara and Raghav Mahobe in Bengaluru; Editing by Anil D'Silva and Shailesh Kuber)
👍️0
SpaceTimeRift777 SpaceTimeRift777 2 년 전
Nice Pump Moon Market
👍️0
tw0122 tw0122 2 년 전
As usual they going to scare folks into
Selling there shares loooks like upper $8s bottom
👍️0
tw0122 tw0122 2 년 전
Still holding about 20% regular short interest and then all the illegal naked Gary G approved ones
👍️0
makinezmoney makinezmoney 2 년 전
$TGTX: Opens at $11...........


Only the beginning now


GO $TGTX
👍️0
tw0122 tw0122 2 년 전
Can be whatever you want if we see $40s..lol
👍️0
Imarket13 Imarket13 2 년 전
God damn thought you were a woman this whole time
👍️0
makinezmoney makinezmoney 2 년 전
$TGTX: I showered.............

Balls, armpits and buttcrack............. good to go.

Took 2mins


GO $TGTX
👍️0
tw0122 tw0122 2 년 전
220pm stand corrected
alfred

@macronewswire
TG THERAPEUTICS (TGTX)TO RESUME TRADING AT 2:20 P.M.
$TGTX
👍️0
Imarket13 Imarket13 2 년 전
I'm hearing within the next hour... everyone wins!!
👍️0
makinezmoney makinezmoney 2 년 전
$TGTX: Fantastic !!!!!!!!!!!!!


Works for me



GO $TGTX
👍️0
tw0122 tw0122 2 년 전
Halted I believe until 830am
Press release tomorrow. Don’t take my word but pretty sure
👍️0
makinezmoney makinezmoney 2 년 전
$TGTX: Whats the big deal about PKPH ???

Did they just get an FDA approval like $TGTX ??

GO $TGTX
👍️0
makinezmoney makinezmoney 2 년 전
$TGTX: No comment


I hope it doesn't open till tomorrow............. then yer filthy for the next 23hrs



GO $TGTX
👍️0
halbroke1 halbroke1 2 년 전
makin..TGTX nice one, Im In !!.Check out pk*ph.., Real cheap
👍️0

최근 히스토리

NASDAQ
TGTX
TG Therapeutics
USOTC
CVVTF
Covestro (PK)
BIT
P1N1V0
BNP Paribas Issuance
NYSE
MS-P
Morgan Stanley
BIT
PRL
Pierrel
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유